Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
RESEARCH TOOLSreports
Holding COYA?
Track your performance easily
COYA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.75 - $10.69
Previous Close$6.5
Volume55.41K
Average Volume (3M)77.69K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$31.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Mar 26, 2025EPS Estimate
-$0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.72
Shares Outstanding16,707,441
10 Day Avg. Volume68,615
30 Day Avg. Volume77,688
Standard Deviation0.19
R-Squared0.00781
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)3.14
Price to Sales (P/S)10.61
Price to Cash Flow (P/CF)-4.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$15.67Price Target Upside135.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Coya Therapeutics, Inc. News
PremiumCompany Announcements
Coya Therapeutics Reports Q3 2024 Highlights and Progress
PremiumCompany Announcements
Coya Therapeutics Advances Pipeline for Neurodegenerative DiseasesPremiumCompany Announcements
Coya Therapeutics Announces Leadership Change and New CEOPremiumCompany Announcements
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial ResultsOwnership Overview
23.01% Insiders
5.79% Mutual Funds
12.83% Other Institutional Investors
53.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
COYA FAQ
What was Coya Therapeutics, Inc.’s price range in the past 12 months?
Coya Therapeutics, Inc. lowest stock price was $4.75 and its highest was $10.69 in the past 12 months.
What is Coya Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Coya Therapeutics, Inc.’s upcoming earnings report date?
Coya Therapeutics, Inc.’s upcoming earnings report date is Mar 26, 2025 which is in 120 days.
How were Coya Therapeutics, Inc.’s earnings last quarter?
Coya Therapeutics, Inc. released its earnings results on Nov 06, 2024. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$0.362 by $0.102.
Is Coya Therapeutics, Inc. overvalued?
According to Wall Street analysts Coya Therapeutics, Inc.’s price is currently Undervalued.
Does Coya Therapeutics, Inc. pay dividends?
Coya Therapeutics, Inc. does not currently pay dividends.
What is Coya Therapeutics, Inc.’s EPS estimate?
Coya Therapeutics, Inc.’s EPS estimate is -$0.3.
How many shares outstanding does Coya Therapeutics, Inc. have?
Coya Therapeutics, Inc. has 16,707,441 shares outstanding.
What happened to Coya Therapeutics, Inc.’s price movement after its last earnings report?
Coya Therapeutics, Inc. reported an EPS of -$0.26 in its last earnings report, beating expectations of -$0.362. Following the earnings report the stock price went up 7.715%.
Which hedge fund is a major shareholder of Coya Therapeutics, Inc.?
Among the largest hedge funds holding Coya Therapeutics, Inc.’s share is Greenlight Capital Inc. It holds Coya Therapeutics, Inc.’s shares valued at 8M.
---
Coya Therapeutics, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.67 (135.64% Upside)
$15.67 (135.64% Upside)
Blogger Sentiment
Bullish
COYA Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $106.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 4.3%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
23.80%
12-Months-Change
Fundamentals
Return on Equity
-50.83%
Trailing 12-Months
Asset Growth
198.87%
Trailing 12-Months
Company Description
Coya Therapeutics, Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
---
COYA Stock 12 Month Forecast
Average Price Target
$15.67
▲(135.64% Upside)
Technical Analysis
Best Analysts Covering COYA
1 Year
1 Year Success Rate
10/14 ratings generated profit
1 Year Average Return
+40.04%
reiterated a buy rating 28 days ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +40.04% per trade.
---